+

WO1997003655A8 - Solution claire et stable d'anti-inflammatoires non steroidiens a integrer dans des gelules de gelatine - Google Patents

Solution claire et stable d'anti-inflammatoires non steroidiens a integrer dans des gelules de gelatine

Info

Publication number
WO1997003655A8
WO1997003655A8 PCT/US1996/010687 US9610687W WO9703655A8 WO 1997003655 A8 WO1997003655 A8 WO 1997003655A8 US 9610687 W US9610687 W US 9610687W WO 9703655 A8 WO9703655 A8 WO 9703655A8
Authority
WO
WIPO (PCT)
Prior art keywords
steroidal anti
inflammatory drugs
clear solutions
incorporation
gelatin capsules
Prior art date
Application number
PCT/US1996/010687
Other languages
English (en)
Other versions
WO1997003655A1 (fr
Inventor
James W Munden
Original Assignee
Upjohn Co
James W Munden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP96923374A priority Critical patent/EP0839029A1/fr
Priority to AU63900/96A priority patent/AU6390096A/en
Application filed by Upjohn Co, James W Munden filed Critical Upjohn Co
Priority to JP50667797A priority patent/JP2001503372A/ja
Publication of WO1997003655A1 publication Critical patent/WO1997003655A1/fr
Publication of WO1997003655A8 publication Critical patent/WO1997003655A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Solutions claires et stables sur les plans chimique et physique de médicaments anti-inflammatoires non stéroïdiens dissous dans du diméthylisosorbide ou dans des mélanges de diméthylisosorbide et d'huiles alimentaires, de propylène glycol, de polysorbate, de polyéthylène glycol ou d'autres véhicules ou solvants couramment employés, pouvant être encapsulées dans des gélules souples de gélatine.
PCT/US1996/010687 1995-07-20 1996-06-26 Solution claire et stable d'anti-inflammatoires non steroidiens a integrer dans des gelules de gelatine WO1997003655A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP96923374A EP0839029A1 (fr) 1995-07-20 1996-06-07 Solution claire et stable d'anti-inflammatoires non steroidiens a integrer dans des gelules de gelatine
AU63900/96A AU6390096A (en) 1995-07-20 1996-06-07 Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
JP50667797A JP2001503372A (ja) 1995-07-20 1996-06-26 非ステロイド系抗炎症剤のゼラチンカプセルへの配合を目的とした安定な透明溶液

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US130495P 1995-07-20 1995-07-20
US1002196P 1996-01-16 1996-01-16
US60/010,021 1996-01-16
US60/001,304 1996-01-16

Publications (2)

Publication Number Publication Date
WO1997003655A1 WO1997003655A1 (fr) 1997-02-06
WO1997003655A8 true WO1997003655A8 (fr) 1999-08-19

Family

ID=26668838

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/010687 WO1997003655A1 (fr) 1995-07-20 1996-06-26 Solution claire et stable d'anti-inflammatoires non steroidiens a integrer dans des gelules de gelatine

Country Status (4)

Country Link
EP (1) EP0839029A1 (fr)
JP (1) JP2001503372A (fr)
AU (1) AU6390096A (fr)
WO (1) WO1997003655A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1348436A1 (fr) * 2002-03-30 2003-10-01 Boehringer Ingelheim International GmbH Suppositoires de meloxicam
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (fr) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Utilisation du meloxicam pour le traitement de maladies respiratoires des porcs
CA2774168C (fr) 2009-09-15 2021-02-23 Ronald Erwin Boch Preparations pharmaceutiques a base de 9-cis-retinyl esters dans un vehicule lipidique
EP2488145B1 (fr) 2009-10-12 2024-04-24 Boehringer Ingelheim Vetmedica GmbH Récipients pour compositions comprenant du méloxicam
US20110090954A1 (en) * 2009-10-21 2011-04-21 Cohen Robert A Video Codes with Directional Transforms
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
GB2477590A (en) * 2010-02-05 2011-08-10 Biocopea Ltd A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
SG10201507819VA (en) 2010-04-19 2015-10-29 Quadra Logic Tech Inc Therapeutic Regimen And Methods For Treating Or Ameliorating Visual Disorders Associated With An Endogenous Retinoid Deficiency
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
CN104470511A (zh) 2012-03-01 2015-03-25 Qlt股份有限公司 用于在与内源性维甲酸类缺乏相关的视觉障碍中改善视觉功能的治疗方案和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria

Also Published As

Publication number Publication date
WO1997003655A1 (fr) 1997-02-06
EP0839029A1 (fr) 1998-05-06
JP2001503372A (ja) 2001-03-13
AU6390096A (en) 1997-02-18

Similar Documents

Publication Publication Date Title
WO1997003655A8 (fr) Solution claire et stable d'anti-inflammatoires non steroidiens a integrer dans des gelules de gelatine
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
KR970012150U (ko) 의약 및 식품용 하드 공 캅셀
DE59712694D1 (de) Stabilisiertes arzneimittel enthaltend cysteinylderivate
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
EP0229022A3 (fr) Compositions pharmaceutiques contenant des analgésiques et de la caféine
FI955091L (fi) Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät alkoholia ja hydrofobista lääkettä
AU3811089A (en) Chewable, edible soft gelatin capsule
AU2029195A (en) Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
AU3807795A (en) Medicinal and/or nutritional microcapsules for per os administration
DE68912232D1 (de) Konjugate zytotoxischer Arzneimittel.
NL300045I2 (nl) Fluorcytidine-derivaten, de bereiding daarvan en geneesmiddelen die deze derivaten bevatten.
CA2168732A1 (fr) Capsules de gelatine renfermant une solution d'acetaminophene fortement concentree
NO874133D0 (no) Delbar, termoplastisk flersjiktsfilm, samt fremgangsmaate for fremstilling av en slik.
NO891152L (no) Innpakningsfilm for matvarer.
FI954105A7 (fi) Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
PL338143A1 (en) Derivatives acylpiperazinylpyrimidines, method of obtaining and drugs containing them
AU3053199A (en) Fused thiophene derivatives and drugs containing the same as the active ingredient
FR2697841B1 (fr) Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2697019B1 (fr) Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
DE69427551D1 (de) Nalbuphinester und diese enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe
MX9201847A (es) Derivados heterociclicos de antiserotoninas, procedimiento para su preparacion y medicamentos que los contienen.
SE8401538L (sv) Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande koffein och forfaranden for anvendning av dessa
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996923374

Country of ref document: EP

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 1997 506677

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1996923374

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1996923374

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: CA

AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): KE LS MW SD SZ UG AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 07/97 UNDER (22) REPLACE "07.06.96" BY "26.06.96"

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载